W4262

1400W dihydrochloride

Name: 1400W dihydrochloride
Brand: SIGMA

>98%, potent and selective iNOS inhibitor , solid

Synonym(s):

N-([3-(Aminomethyl)phenyl]methyl)ethanimidamide dihydrochloride

Select a Size

About This Item

Empirical Formula (Hill Notation):

C₁₀H₁₅N₃· 2 HCl

CAS Number:

214358-33-5

Molecular Weight:

250.17

MDL number:

MFCD03428622

UNSPSC Code:

12352200

PubChem Substance ID:

24278778

NACRES:

NA.77

Key Documents

View All Documentation

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Product Name

1400W dihydrochloride, >98%, solid

Quality Level

100

Assay

>98%

form

solid

storage condition

desiccated

originator

GlaxoSmithKline

shipped in

wet ice

storage temp.

−20°C

SMILES string

Cl[H].Cl[H].CC(=N)NCc1cccc(CN)c1

InChI

1S/C10H15N3.2ClH/c1-8(12)13-7-10-4-2-3-9(5-10)6-11;;/h2-5H,6-7,11H2,1H3,(H2,12,13);2*1H

InChI key

WDJHSQZCZGPGAA-UHFFFAOYSA-N

Gene Information

human ... NOS1(4842), NOS2(4843), NOS3(4846)

Related Categories

Bioactive Small Molecule Inhibitors

Bioactive Small Molecules

Application

1400W dihydrochloride has been used:

as a strong inhibitor of inducible nitric oxide to analyse its effect on intestinal ischemia/reperfusion (I/R) injury model in rat
as inducible nitric oxide synthase (iNOS)-selective inhibitor, to elucidate the mechanism of PM10-induced endothelial dysfunction
to study its efficacy on renal ischemia/ reperfusion injury in rats
as iNOS inhibitor to investigate its ability to counteract spatial memory deficits after hypobaric hypoxia reoxygenation

Biochem/physiol Actions

1400W dihydrochloride is a potent and selective inhibitor of inducible nitric oxide synthase (iNOS).

Features and Benefits

This compound is featured on the Nitric Oxide Synthases page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by GlaxoSmithKline. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Storage Class Code

11 - Combustible Solids

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS

Ersoz N, et al.

Renal Failure, 31(8), 704-710 (2009)

Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor.

L L Thomsen et al.

Cancer research, 57(15), 3300-3304 (1997-08-01)

We have investigated the effect of N-(3-(aminomethyl)benzyl)acetamidine (1400W), a novel and highly selective inhibitor for inducible NOS (iNOS), on in vivo growth of solid tumors expressing iNOS. For the EMT6 murine mammary adenocarcinoma, in which iNOS is expressed in the

Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion

Kesik V, et al.

The Journal of Surgical Research, 157(1), e97-e105 (2009)

Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity.

Simone Bido et al.

Nature communications, 12(1), 6237-6237 (2021-10-31)

Recent findings in human samples and animal models support the involvement of inflammation in the development of Parkinson's disease. Nevertheless, it is currently unknown whether microglial activation constitutes a primary event in neurodegeneration. We generated a new mouse model by

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration.

Jieyu Xu et al.

International journal of biological sciences, 16(9), 1563-1574 (2020-04-01)

The production of nitric oxide (NO) is a key feature of immunosuppressive myeloid cells, which impair T cell activation and proliferation via reversibly blocking interleukin-2 receptor signaling. NO is mainly produced from L-arginine by inducible NO synthase (iNOS). Moreover, L-arginine

View All Related Papers

Articles

DISCOVER Bioactive Small Molecules for Nitric Oxide & Cell Stress Research

1400W dihydrochloride

>98%, potent and selective iNOS inhibitor , solid

Select a Size

About This Item

Key Documents

Properties

Product Name

Quality Level

Assay

form

storage condition

originator

shipped in

storage temp.

SMILES string

InChI

InChI key

Gene Information

Related Categories

Description

Application

Biochem/physiol Actions

Features and Benefits

Safety Information

Storage Class Code

WGK

Flash Point(F)

Flash Point(C)

Personal Protective Equipment

Documentation

Certificates of Analysis (COA)

Already Own This Product?

Peer Reviewed Papers

Protocols and Articles

Articles

Related Content

Technical Service